Nath Bio-Genes - News
NSE: NATHBIOGEN | BSE: 537291
₹131.01
As on 30-Oct-2026 15:31IST
Market cap
₹251 Cr
Revenue (TTM)
₹490 Cr
P/E Ratio
6.9
P/B Ratio
0.4
Div. Yield
1.5 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCorporate Action-Board to consider Dividend
05-Sep-2026Corporate Action-Board to consider Dividend
04-Sep-2026Intimation Of Annual General Meeting
01-Sep-2026Announcement Under Reg 30 Of SEBI (LODR)
06-Aug-2026No News & Announcements are available.